Skip to main content

Table 2 Survival analysis demonstrating association between age, PSA, cT, GS and BSI at baseline

From: Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy

Variable at baseline

N

Hazard ratio

pvalue

Univariate analysis

   

Age

146

1.02 (0.99 to 1.05)

0.21

PSA

146

1.0002 (1.0000 to 1.0003)

0.02

cT

131

2.40 (1.43 to 4.04)

0.0009

GS

135

1.84 (1.38 to 2.46)

<0.0001

BSI

146

1.27 (1.19 to 1.36)

<0.0001

Multivariate analysis

   

Age

121

1.02 (0.98 to 1.06)

0.28

PSA

121

0.9999 (0.9998 to 1.0002)

0.80

cT

121

2.20 (1.28 to 3.78)

0.004

GS

121

1.86 (1.34 to 2.58)

0.0002

Multivariate analysis

   

Age

121

1.03 (0.99 to 1.06)

0.10

PSA

121

0.9999 (0.9997 to 1.0002)

0.58

cT

121

1.95 (1.16 to 3.28)

0.01

GS

121

1.99 (1.43 to 2.779)

<0.0001

BSI

121

1.26 (1.16 to 1.37)

<0.0001

  1. PSA, prostate-specific antigen; cT, clinical stage; GS, Gleason score; BSI,Bone Scan Index; N, number of patients.